Abstract:Sustained activation of β adrenergic receptor (βAR) leads to pathologic cardiac hypertrophy. However, the related mechanisms still remain unclear. In this study, we observe how N-acetylcysteine (NAC) affects the oxidative stress and calcium/calmodulin-dependent protein kinase II (CaMKII) expression in heart of isoproterenol (ISO)-stimulated rats, and investigate whether oxidative stress and CaMKII contribute to the development of sustained βAR-stimulated cardiac hypertrophy. Healthy male Wistar rats were randomly separated into 4 groups: control (CTRL), ISO-treated (ISO), control with NAC supplement (CTRL+NAC) and ISO-treated with NAC supplement (ISO+NAC) groups (6 rats in each group). Systolic blood pressure (SBP) was measured in awake rats with the tail-cuff method every week for two weeks. Heart weight/body weight ratio (HW/BW) and HE staining were used for the detection of myocardial hypertrophy. Myocardial mitochondrial reactive oxygen species (ROS) levels were measured by DCF fluorometry. The expressions of activated-CaMKII (p-CaMKII/CaMKII) and NADPH oxidase 4 (NOX(4)) were determined by Western blot analysis. The results showed that ISO-treated (i.p., daily 3 mg/kg, 2 weeks) rats developed an obvious cardiac hypertrophy as expressed by increases of HW/BW and myocyte cross-section area. Cardiac mitochondrial ROS level was significantly enhanced in ISO group as compared to CTRL group (P < 0.05). The expressions of NOX(4) and p-CaMKII in ISO group were also up-regulated as compared to CTRL group (1.4 and 1.6 times of CTRL, respectively, P < 0.05). NAC supplement significantly suppressed the hypertrophic development of heart in ISO-stimulated rats. The cardiac mitochondrial ROS level showed a significant decrease in rats of ISO+NAC group (P < 0.05 vs ISO). In accordance with this, ISO+NAC group rats also showed marked reductions in the expressions of NOX(4) and p-CaMKII/CaMKII compared to ISO group rats (P < 0.05). There were no significant differences of the detected indices between the rats from CTRL+NAC and CTRL groups. SBP showed no differences among four groups. These results suggest that both oxidative stress and CaMKII play important roles in sustained βAR-stimulated cardiac hypertrophy. NAC may suppress ISO-induced cardiac hypertrophy by down-regulating the expression of activated-CaMKII, and by reducing the level of oxidative stress originated from mitochondria and NADPH oxidase pathways.

BST-1 aggravates aldosterone-induced cardiac hypertrophy via the Ca2+ /CaN/NFATc3 pathway

The Role of Calcineurin-dependent Signal Transduction on Cardiac Hypertrophy Induced by Aldosterone in Rats

Cardiac-specific BACH1 Ablation Attenuates Pathological Cardiac Hypertrophy by Inhibiting the Ang II Type 1 Receptor Expression and the Ca2+/CaMKII Pathway.

Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.

Cathepsin B Deficiency Attenuates Cardiac Remodeling in Response to Pressure Overload Via TNF-α/ASK1/JNK Pathway

Sodium Tanshinone Iia Sulfonate Depresses Angiotensin Ii-Induced Cardiomyocyte Hypertrophy Through Mek/Erk Pathway

Β3-Adrenergic Receptor Activation Induces TGFβ1 Expression in Cardiomyocytes Via the PKG/JNK/c-Jun Pathway.

Tanshinone Iia Protects Against Cardiac Hypertrophy Via Inhibiting Calcineurin/Nfatc3 Pathway

Tanshinol Borneol Ester Improves Pressure Overload-Induced Cardiac Hypertrophy Through Mitigating Autophagy

Transforming growth factor-β and bone morphogenetic protein signaling pathways in pathological cardiac hypertrophy

The Effect of Tanshinone Iia Upon the Tgf-Beta1/Smads Signaling Pathway in Hypertrophic Myocardium of Hypertensive Rats

[Involvement of Calcineurin-Dependent Signal Pathway in the Angiotensin II-induced Cardiac Myocyte Hypertrophy].

Activation of the Cardiac Proteasome Promotes Angiotension II-induced Hypertrophy by Down-Regulation of ATRAP.

Effects of a New Angiotensin Type 1 Receptor Antagonist Ib on the Cardiac Hypertrophy Induced by L-thyroxin in Rats

Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension

Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling

Aldosterone suppresses cardiac mitochondria

SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.

Effects of Sodium Ferulate on Cardiac Hypertrophy Are via the CaSR-Mediated Signaling Pathway

Stem Cell Antigen 1 Protects Against Cardiac Hypertrophy And Fibrosis After Pressure Overload

[Oxidative Stress and Calcium/calmodulin-Dependent Protein Kinase II Contribute to the Development of Sustained Β Adrenergic Receptor-Stimulated Cardiac Hypertrophy in Rats].